JPRN-UMIN000009647Not yet recruiting未知
Efficacy of treatments for Japanese cedar pollinosis based on guideline -combined treatment ofleukotriene receptor antagonist with H1 receptor antagonists - Combined treatment of LTRA with H1RA
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Okayama University
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16years-old to 65years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) concomitant sinonasal disease that could potentially affect the outcome of the trial (e.g., nasal polyps, rhinosinusitis, nasal septum deviation); (2) concomitant treatment for AR caused by allergens other than Japanese cedar/cypress pollen; (3) rhinitis medicamentosa and non-infectious, non-allergic rhinitis; (4) medication with anti-allergic drugs including H1RA, chromones, glucocorticoids and decongestants within 2 weeks of study initiation; (5) cedar pollen-specific immunotherapy; (6) sinonasal surgery including laser vaporization of inferior turbinates within 6 months;(7) concomittant uncontrolled asthma (8) hypersensitivity to INS and H1RA (9)systemic infection including mycosis; or (10) were pregnant and breastfeeding.
Investigators
Similar Trials
Completed
Phase 3
Protective effect of Japanese cedar pollinosis by Lactobacillus strain (KW3110)JPRN-UMIN000000863Graduate School of Medicine, Chiba University50
Completed
Not Applicable
sublingual immunotherapy for Japanese cedar pollinosis: multicenter trialJPRN-UMIN000003950ippon Medical School200
Completed
Not Applicable
sublingual immunotherapy for Japanese cedar pollinosisJapanese cedar pollinosisJPRN-UMIN000016532Bureau of social welfare and public health, Tokyo Metropolitan Goverment200
Recruiting
Not Applicable
Effects of artificial exposure of Japanese cedar pollen on expression of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosisPollinosisJPRN-UMIN000007157niversity of Tokushima40
Completed
Phase 2
The clinical efficacy of Japanese Cayratia Herb combined with mesalazine in the treatment of ulcerative colitis: a randomized controlled clinical trialJapanese Cayratia Herb (Cayratia japonica (Thunb.) Gagnep)mesalazineRandomized controlled trialulcerative colitisUlcerative colitisTCTR20230913006ijiang Ji94